PeptideDB

SBFI (sodium ion fluorescence probe; Sodium-binding benzofuran isophthalate) 124549-08-2

SBFI (sodium ion fluorescence probe; Sodium-binding benzofuran isophthalate) 124549-08-2

CAS No.: 124549-08-2

SBFI is a membrane permeable (penetrable) fluorescent Na+ indicator dye. SBFI is excited at 340 nm and collects fluoroph
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

SBFI is a membrane permeable (penetrable) fluorescent Na+ indicator dye. SBFI is excited at 340 nm and collects fluorophore emission at 450 nm. SBFI is more selective for Na+ than K+, with Kds of 20 and 120 mM for these ions, respectively.

Physicochemical Properties


Molecular Formula C44H42N2O15.4[H3N]
Molecular Weight 906.930760000001
Exact Mass 838.259
CAS # 124549-08-2
PubChem CID 123881
Appearance Typically exists as solid at room temperature
Density 1.37g/cm3
Boiling Point 1034.1ºC at 760 mmHg
Flash Point 579.2ºC
Vapour Pressure 0mmHg at 25°C
Index of Refraction 1.628
LogP 6.829
Hydrogen Bond Donor Count 4
Hydrogen Bond Acceptor Count 17
Rotatable Bond Count 10
Heavy Atom Count 61
Complexity 1380
Defined Atom Stereocenter Count 0
SMILES

COC1=CC2=C(C=C1N3CCOCCN(CCOCCOCC3)C4=CC5=C(C=C(C6=C(C=C(C=C6)C(=O)O)C(=O)O)O5)C=C4OC)OC(=C2)C7=C(C=C(C=C7)C(=O)O)C(=O)O

InChi Key UGJCNRLBGKEGEH-UHFFFAOYSA-N
InChi Code

InChI=1S/C44H42N2O15/c1-55-39-21-27-19-37(29-5-3-25(41(47)48)17-31(29)43(51)52)60-35(27)23-33(39)45-7-11-57-12-8-46(10-14-59-16-15-58-13-9-45)34-24-36-28(22-40(34)56-2)20-38(61-36)30-6-4-26(42(49)50)18-32(30)44(53)54/h3-6,17-24H,7-16H2,1-2H3,(H,47,48)(H,49,50)(H,51,52)(H,53,54)
Chemical Name

4-[6-[13-[2-(2,4-dicarboxyphenyl)-5-methoxy-1-benzofuran-6-yl]-1,4,10-trioxa-7,13-diazacyclopentadec-7-yl]-5-methoxy-1-benzofuran-2-yl]benzene-1,3-dicarboxylic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro For every sample, the SBFI dye is prepared using the following procedure: [1] 1. Melt the suitable quantity of color powder in 3 milliliters of dimethyl sulfoxide. 2. For five minutes, mix the five solutions. 3. The fluorescence levels of each sample were then measured under a Leitz Orthoplan microscope after they had been subjected to UV radiation. 4. For every solution, take ten readings in total, stirring in between. 5. Plot the greatest, lowest, and median values according to dye concentration for each set of sample results. 6. Using 50 μg of SBFI dye, the ideal fluorescence value with the least amount of variation in the upper and lower bounds was found based on these tests.
References

[1]. Leeves MA, The effect of mechanical deformation on the distribution of ions in fibroblasts. Am J Orthod Dentofacial Orthop. 1995 Jun;107(6):625-32.

[2]. Minta A, Fluorescent indicators for cytosolic sodium. J Biol Chem. 1989 Nov 15;264(32):19449-57.

Additional Infomation Sodium-binding benzofuran isophthalate is a crown compound that is 1,4,10-trioxa-7,13-diazacyclopentadecane in which the hydrogens of the amino groups at position 7 and 13 are replaced by 2-(2,4-dicarboxyphenyl)-5-methoxy-1-benzofuran-6-yl groups. It is a cell-impermeant fluorescent sodium indicator. It has a role as a fluorochrome. It is a member of 1-benzofurans, a tetracarboxylic acid, a crown compound and an aromatic ether.

Solubility Data


Solubility (In Vitro) May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
Solubility (In Vivo) Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

Injection Formulations
(e.g. IP/IV/IM/SC)
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution 50 μL Tween 80 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO 400 μLPEG300 50 μL Tween 80 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO 100 μLPEG300 200 μL castor oil 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol 100 μL Cremophor 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300:Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH 400 μLPEG300 50 μL Tween 80 450 μL Saline)

Oral Formulations Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).
Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders

Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.1026 mL 5.5131 mL 11.0262 mL
5 mM 0.2205 mL 1.1026 mL 2.2052 mL
10 mM 0.1103 mL 0.5513 mL 1.1026 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.